New
HealthMore in Health →
Gene Therapy Targets a Hard-to-Treat Cystic Fibrosis Mutation
Researchers at the University of Trento report an mRNA-based genome-editing approach aimed at a cystic fibrosis mutation that affects about 10% of patients and does not respond to some current drug therapies.
Key Takeaways
- Researchers targeted the 1717-1G >A mutation in cystic fibrosis.
- The mutation affects about 10% of patients and does not respond to some current therapies.
DE
DT Editorial AI··via medicalxpress.com